FDA
Why Your “Ozempic” May Not Be Ozempic: FDA Warnings Highlight Growing Risks of Unregulated GLP-1 Drugs
As demand for GLP-1 medications used to treat diabetes and obesity continues to surge, federal health officials are warning consumers that not ever...
- Jessica Wilson
What Is Cyclosporiasis? The Foodborne Illness Showing Up in the News
As summer brings more fresh fruit, salads, herbs and cookout meals to the table, health officials are watching a foodborne illness that many people...
- Subash Kafle
As GLP-1 Shortages Ease, Patient Safety Concerns Shift to Unsafe Copies
Unsafe compounded GLP-1 drugs remain a public health concern even as the FDA says shortages of major GLP-1 medications have eased. Federal official...
- Subash Kafle
FDA begins to draw the line on AI chatbots in healthcare
The Food and Drug Administration is moving from broad discussion to real-world oversight of AI chatbots in healthcare, and that shift is becoming m...
- Subash Kafle
Low COVID and Flu Booster Uptake in 2025 Raises Public Health Concerns
As the United States moves deeper into the 2025–26 respiratory virus season, public health officials are raising concern about persistently low rat...
- Jessica Wilson
Longtime FDA Innovator Richard Pazdur Appointed Director of the Center for Drug Evaluation and Research
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced on November 11,...
- Victor Mejia
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
